• Je něco špatně v tomto záznamu ?

Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancer

A. Rozsypalova, B. Rosova, A. Filipova, DH. Nikolov, R. Chloupkova, I. Richter, J. Proks, R. Zachoval, R. Matej, B. Melichar, T. Buchler, J. Dvorak,

. 2019 ; 24 (4) : 1644-1651. [pub] -

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005763

PURPOSE: The aim of this study was to investigate the potential association and combined prognostic significance of the frequency of primary cilia (PC), programmed cell death protein-1 receptor (PD1) and CD8+ tumor infiltrating lymphocytes (TIL) in patients with clear cell renal cancer (ccRCC). METHODS: The frequency of PC, PD1 expression and the frequency of intratumoral CD8+ TIL were evaluated in 104 ccRCC patients. RESULTS: The median frequency of PC was 0.003. The expression of PD1+ cells were <5% in 52 patients, 5-25% in 34 patients and 26-50% in 13 patients and >50% in 5 patients. Intratumoral CD8+ TIL were evaluable in all patients: negative in 1 patient, <25% in 63, 26-50% in 29 and >50% in 11 patients. Overall survival (OS) according to the frequency of PC was significantly shorter in patients with higher frequency (≥0.002) than in patients with lower frequency (<0.002) (p<0.001). Median OS was significantly shorter in patients with higher (25%) CD8+ TIL and higher (>25%) PD1+ expression than in patients with lower (<25%) expression (4.6 vs. 97. years, p=0.006 and 2.9 vs. 8.9 years, p=0.006, respectively). CONCLUSIONS: The present study provides the first data on the potential association and combined prognostic significance of frequency of PC, PD1+ cells and CD8+ TIL in patients with clear cell renal cancer.

000      
00000naa a2200000 a 4500
001      
bmc20005763
003      
CZ-PrNML
005      
20200528105354.0
007      
ta
008      
200511s2019 gr f 000 0|eng||
009      
AR
035    __
$a (PubMed)31646820
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Rozsypalova, Aneta $u 1Department of Oncology, First Medical Faculty, Charles University and Thomayer Hospital, Prague, Czech Republic.
245    10
$a Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancer / $c A. Rozsypalova, B. Rosova, A. Filipova, DH. Nikolov, R. Chloupkova, I. Richter, J. Proks, R. Zachoval, R. Matej, B. Melichar, T. Buchler, J. Dvorak,
520    9_
$a PURPOSE: The aim of this study was to investigate the potential association and combined prognostic significance of the frequency of primary cilia (PC), programmed cell death protein-1 receptor (PD1) and CD8+ tumor infiltrating lymphocytes (TIL) in patients with clear cell renal cancer (ccRCC). METHODS: The frequency of PC, PD1 expression and the frequency of intratumoral CD8+ TIL were evaluated in 104 ccRCC patients. RESULTS: The median frequency of PC was 0.003. The expression of PD1+ cells were <5% in 52 patients, 5-25% in 34 patients and 26-50% in 13 patients and >50% in 5 patients. Intratumoral CD8+ TIL were evaluable in all patients: negative in 1 patient, <25% in 63, 26-50% in 29 and >50% in 11 patients. Overall survival (OS) according to the frequency of PC was significantly shorter in patients with higher frequency (≥0.002) than in patients with lower frequency (<0.002) (p<0.001). Median OS was significantly shorter in patients with higher (25%) CD8+ TIL and higher (>25%) PD1+ expression than in patients with lower (<25%) expression (4.6 vs. 97. years, p=0.006 and 2.9 vs. 8.9 years, p=0.006, respectively). CONCLUSIONS: The present study provides the first data on the potential association and combined prognostic significance of frequency of PC, PD1+ cells and CD8+ TIL in patients with clear cell renal cancer.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a CD8-pozitivní T-lymfocyty $x patologie $7 D018414
650    _2
$a karcinom z renálních buněk $x genetika $x patologie $7 D002292
650    _2
$a cilie $x genetika $x patologie $7 D002923
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a tumor infiltrující lymfocyty $x patologie $7 D016246
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a prognóza $7 D011379
650    _2
$a antigeny CD279 $x genetika $7 D061026
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rosova, Blanka
700    1_
$a Filipova, Alzbeta
700    1_
$a Nikolov, Dimitar Hadzi
700    1_
$a Chloupkova, Renata
700    1_
$a Richter, Igor
700    1_
$a Proks, Jan
700    1_
$a Zachoval, Roman
700    1_
$a Matej, Radoslav
700    1_
$a Melichar, Bohuslav
700    1_
$a Buchler, Tomas
700    1_
$a Dvorak, Josef
773    0_
$w MED00005361 $t Journal of B.U.ON. : official journal of the Balkan Union of Oncology $x 2241-6293 $g Roč. 24, č. 4 (2019), s. 1644-1651
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31646820 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200528105352 $b ABA008
999    __
$a ok $b bmc $g 1524621 $s 1095819
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 24 $c 4 $d 1644-1651 $e - $i 2241-6293 $m Journal of Balkan Union of Oncology $n J BUON $x MED00005361
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...